From viral vectors to nucleic acids: biopharma’s evolving manufacturing landscape
By Caroline Peachey (European Pharmaceutical Review)
European Commission authorises one of first ustekinumab biosimilars in Europe
By Catherine Eckford (European Pharmaceutical Review)
Research calls for greater investment in Alzheimer’s clinical trials
By Catherine Eckford (European Pharmaceutical Review)
AAV gene therapy demonstrates positive activity in Duchenne muscular dystrophy
By Catherine Eckford (European Pharmaceutical Review)
What is the future of biologic medicines?
By Catherine Eckford (European Pharmaceutical Review), Sigma Mostafa (KBI Biopharma)